p53 protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: Is it an early or late event?

American Journal of Gastroenterology

Volumn 91, Issue 1, 1996, Pages 11-14

  Levi, E ^a   Stryker, S J ^a   Rao, M S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOMATOUS POLYP; ADULT; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROADENOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029670701     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Stryker SJ, Wolff BG, Culp CE, et al. The natural history of untreated colon polyps. Gastroenterology 1987;93:1009-13.
2. Madara JL, Harte P, Deasy J, et al. Evidence for an adenoma-carcinoma sequence in dimethylhydrazine-induced neoplasms of rat intestinal epithelium. Am J Pathol 1983;110:230-5.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature (London) 1992;359: 235-7.
5. Wasylshyn ML, Westbrook CA. Genetic abnormalities of colorectal carcinoma. Hepatogastroenterol 1992;39:226-31.
6. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature (London) 1987;327: 293-7.
7. Sasaki M, Okamoto M, Sato C, et al. Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with nonpolyposis colorectal carcinoma. Cancer Res 1989; 49:4402-6.
8. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993;1155:181-205.
9. Lane DP, Benchimol S. p53: Oncogene or anti-oncogene? Gene Develop 1990;4:1-8.
10. Porter PL, Gown AM, Kramp SG, et al. Widespread p53 overexpression in human malignant tumorsAn immunohistochemical study using methacam-fixed embedded tissue. Am J Pathol 1992;140:145-53.
11. Fujimoto K, Yamada Y, Okajima E, et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 1992;52:1393-8.
12. Bennett WP, Hollstein MC, Metcalf RA, et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992;52:6092-7.
13. Ro YS, Cooper PN, Lee JA, et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993;128:237-41.
14. Ali IU, Schweitzer JB, Ikejiri B, et al. Heterogeneity of subcellar localization of p53 protein in human glioblastomas. Cancer Res 1994;54:1-5.
15. Shirasawa S, Urabe K, Yanagawa Y, et al. p53 gene mutations in colorectal tumors from patients with familial polyposis coli. Cancer Res 1991;51:2874-8.
16. Kaklamanis L, Gatter KC, Mortensen N, et al. p53 expression in colorectal adenomas. Am J Pathol 1993;142:87-93.
17. Shiao Y, Rugge M, Correa P, et al. p53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.
18. Bennett WP, Colby TV, Travis WD, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993;53:4817-22.
19. Lassam NJ, From L, Kahn HJ. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 1993;53: 2235-8.
20. Baker S, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
21. Kawasaki Y, Monden T, Morimoto H, et al. Immunohistochemical study of p53 expression in microwave-fixed paraffin embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 1992; 97:244-9.
22. Purdie CA, O'Grady J, Piris, et al. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-13.
23. Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer 1994;57:623-7.
24. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
25. Baas IO, Mulder JR, Offerhaus JA, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
26. Rodrigues NR, Rowan A, Smith MET, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
27. Maskens AP. Histogenesis of adenomatous polyps in the human large intestine. Gastroenterology 1979;77:1245-51.
28. Morson BC, Dawson MP, Day DW, et al. Gastrointestinal pathology, 3rd ed. London: Blackwell Scientific Publications, 1990: 563-96.
29. Gown AM, de Wever N, Battifora H. Microwave-based antigen unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1:256-66.
30. Ichii S, Takeda S, Horii A, et al. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 1993;8:2399-405.
31. Scott N, Bell SM, Sagar P, et al. p53 expression and k-ras mutation in colorectal adenomas. Gut 1993;34:621-4.
32. Yukawa M, Fujimori T, Narda S, et al. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumors. Gut 1994;35:1258-61.